Trade Direction:
Injective Spot Long
Risk Management:
- Spot Position 1% total spot portfolio.
- SL will be executed only when a daily / 3day close below that level.
Reason for Entry:
- 50% retracement off daily leg completed
- EQLs swept and reclaimed
- Daily CHoCH/MSB with retrace
- Injective oversold daily with likely daily bullish divergence forming
- Multiple fair value gaps tapped: daily, 3-day, weekly — strong support confluence
Additional Notes:
- Plan to layer bids in and slowly dca in even if that means higher up
- If this low is confirmed as a protected level, stop to be moved tighter as trade progresses
- Daily time frame change of control favours bulls, supporting long bias
Only coin I'm interested in at these levels. Begun building a spot position here.
Injective Spot Long
Risk Management:
- Spot Position 1% total spot portfolio.
- SL will be executed only when a daily / 3day close below that level.
Reason for Entry:
- 50% retracement off daily leg completed
- EQLs swept and reclaimed
- Daily CHoCH/MSB with retrace
- Injective oversold daily with likely daily bullish divergence forming
- Multiple fair value gaps tapped: daily, 3-day, weekly — strong support confluence
Additional Notes:
- Plan to layer bids in and slowly dca in even if that means higher up
- If this low is confirmed as a protected level, stop to be moved tighter as trade progresses
- Daily time frame change of control favours bulls, supporting long bias
Only coin I'm interested in at these levels. Begun building a spot position here.
Trade active
Additional fills have been executed. Layered bids all the way down to 10.23 if market gives.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.